Authors
Loading...
Randomized trial evaluates an ion-activated ocular gel of timolol maleate in glaucoma, suggesting enhanced patient compliance.
Pandey et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: